Literature DB >> 15450849

Factor X activator from Vipera lebetina venom is synthesized from different genes.

Ene Siigur1, Anu Aaspõllu, Katrin Trummal, Külli Tõnismägi, Indrek Tammiste, Nisse Kalkkinen, Jüri Siigur.   

Abstract

Vipera lebetina venom contains specific coagulant Factor X activator (VLFXA) that cleaves the Arg52-Ile53 bond in the heavy chain of human factor X. VLFXA is a glycoprotein that is composed of a heavy chain (HC) and two light chains (LC) linked by disulfide bonds. The complete amino acid sequences of the three chains of the factor X activator from V. lebetina snake venom are deduced from the nucleotide sequences of cDNAs encoding these chains. The full-length cDNA (2347 bp) sequence of the HC encodes an open reading frame (ORF) of 612 amino acids that includes signal peptide, propeptide and mature metalloproteinase with disintegrin-like and cysteine-rich domains. The light chain LC1 contains 123 and LC2 135 amino acid residues. Both light chains belong to the class of C-type lectin-like proteins. The N-termini of VLFXA chains and inner sequences of peptide fragments detected by liquid chromatography-electrospray ionization tandem mass spectrometry (LC MS/MS) from protein sequence are 100% identical to the sequences deduced from the cDNA. The molecular masses of tryptic fragments of VLFXA chains analyzed by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) also confirm the protein sequences deduced from the cDNAs. These are the first cloned factor X activator heavy and light chains. We demonstrate that the heavy and light chains are synthesized from different genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450849     DOI: 10.1016/j.bbapap.2004.07.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  cDNA cloning, expression and fibrin(ogen)olytic activity of two low-molecular weight snake venom metalloproteinases.

Authors:  Ying Jia; Sara Lucena; Esteban Cantu; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2009-04-16       Impact factor: 3.033

2.  Phylogenetic analysis of serine proteases from Russell's viper (Daboia russelli siamensis) and Agkistrodon piscivorus leucostoma venom.

Authors:  Pattadon Sukkapan; Ying Jia; Issarang Nuchprayoon; John C Pérez
Journal:  Toxicon       Date:  2011-05-27       Impact factor: 3.033

3.  CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification.

Authors:  Fatah Chérifi; Jean-Claude Rousselle; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

4.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

5.  Synergistic Effect of Proteinase Activity by Purification and Identification of Toxic Protease From Nemopilema nomurai.

Authors:  Chunlin Yu; Rongfeng Li; Xiujing Yin; Huahua Yu; Pengcheng Li
Journal:  Front Pharmacol       Date:  2021-11-25       Impact factor: 5.810

6.  Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.

Authors:  Nicholas R Casewell; Robert A Harrison; Wolfgang Wüster; Simon C Wagstaff
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

7.  Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells.

Authors:  Mari Samel; Heiki Vija; Imbi Kurvet; Kai Künnis-Beres; Katrin Trummal; Juhan Subbi; Anne Kahru; Jüri Siigur
Journal:  Toxins (Basel)       Date:  2013-01-24       Impact factor: 4.546

8.  Snake Venom Cytotoxins, Phospholipase A2s, and Zn2+-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance.

Authors:  Sardar E Gasanov; Ruben K Dagda; Eppie D Rael
Journal:  J Clin Toxicol       Date:  2014-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.